Tag: NASDAQ:CARM

Science

Investors In Carisma Therapeutics Inc (CARM) Will Start Making Money Again

Carisma Therapeutics Inc (NASDAQ:CARM) has a beta value of 1.67 and has seen 15.98 million shares traded in the last trading session. The company, currently

Science

Carisma Therapeutics Inc (NASDAQ: CARM) Is Up 72.0% From Its 52-Week Low; YTD, It Is Up 19.94% – What To Do Now

During the last session, Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares were 2.89 million, with the beta value of the company hitting 1.69. At the end

Science

After Sinking 242.73% During Past Week, Is Carisma Therapeutics Inc (NASDAQ: CARM) Still A Buy?

Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares stood at 36.57 million during the last session, with the company’s beta value hitting 2.04. At the close of

Company

Is Carisma Therapeutics Inc (NASDAQ: CARM) Stock Set To Rise More?

In the latest trading session,, 0.93 million Carisma Therapeutics Inc (NASDAQ:CARM) shares changed hands as the company’s beta touched 1.70. With the company’s most recent

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: NASDAQ:CARM

Investors In Carisma Therapeutics Inc (CARM) Will Start Making Money Again

Carisma Therapeutics Inc (NASDAQ: CARM) Is Up 72.0% From Its 52-Week Low; YTD, It Is Up 19.94% – What To Do Now

After Sinking 242.73% During Past Week, Is Carisma Therapeutics Inc (NASDAQ: CARM) Still A Buy?

Is Carisma Therapeutics Inc (NASDAQ: CARM) Stock Set To Rise More?

Quick Links

Categories